Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 83-91

  Van Steenis, M N A ^a   Driesenaar, J A ^b   Bensing, J M ^a,b   Van Hulten, R ^a   Souverein, P C ^a   Van Dijk, L ^a,b   De Smet, P A G M ^c   Van Dulmen, A M ^b,c,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

Author keywords

Adherence; Asthma; Asthma symptoms; Inhaled corticosteroids; Medication beliefs

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTHMA; ATTITUDE TO HEALTH; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BELIEF; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SELF REPORT;

EID: 84892575311     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S44185     Document Type: Article

References (48)

1. LAN [Lung Alliance The Netherlands]. Goed gebruik inhalatiemedicatie astma en COPD [Proper use inhalation medication asthma and COPD]. 2011. Available from: http://www.longalliantie.nl/publicaties-. Accessed June 12, 2013.
2. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204.
3. Meltzer EO. The role of the immune system in the pathogenesis of asthma and an overview of the diagnosis, classification, and current approach to treating the disease. J Manag Care Pharm. 2003;9(Suppl 5):8-13.
4. Scichilone N, Contino A, Figlioli GB, Paglino G, Bellia V. Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options. Patient Prefer Adherence. 2010;4:17-23.
5. Geijer RMM. NHG Standaarden voor de Huisarts. [NHG Standards for General Practioners]. Houten, The Netherlands: Bohn Stafleu van Loghum; 2011. Dutch.
6. Global Initiative for Asthma. From the Global Strategy for Asthma Management and Prevention. 2012. Available from: http://www.ginasthma.org/. Accessed June 12, 2013.
7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
8. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130(Suppl 1):65S-72S.
9. Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64:47-54.
10. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288-1293.
11. Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35:207.
12. Van Dijk L, Heerdink ER, Somai D, et al. Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res. 2007;7:51.
13. Laforest L, El Hasnaoui A, Pribil C, et al. Asthma patients' self-reported behaviours toward inhaled corticosteroids. Respir Med. 2009;103: 1366-1375.
14. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
15. Williams LK, Peterson EL, Wells K, et al. A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. J Allergy Clin Immunol. 2010;126: 225-231.
16. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1-24.
17. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining nonadherence to preventer medication. Psychol Health. 1999;14:1-24.
18. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074-1090.
19. Fialko L, Garety PA, Kuipers E, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008;100:53-59.
20. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J. 2009;18:300-305.
21. Hermosa JL, Sanchez CB, Rubio MC, Minguez MM, Walther JL. Factors associated with the control of severe asthma. J Asthma. 2010;47:124-130.
22. Molimard M, Le Gros V. Impact of patient-related factors on asthma control. J Asthma. 2008;45:109-113.
23. Schatz M. Predictors of asthma control: what can we modify? Curr Opin Allergy Clin Immunol. 2012;12:263-268.
24. Bae YJ, Kim TB, Jee YK, et al. Severe asthma patients in Korea overestimate their adherence to inhaled corticosteroids. J Asthma. 2009;46:591-595.
25. Suzuki T, Saito I, Adachi M, Shimbo T, Sato H. Influence of patients' adherence to medication, patient background and physicians' compliance to the guidelines on asthma control. Yakugaku Zasshi. 2011;131:129-138.
26. World Health Organization Collaborating Centre for Drugs Statistics Methodology. ATC/DDD Index 2013. Available from: http://whocc.no/atc_ddd_index. Accessed June 12, 2013.
27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
28. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 2000;50:166-171.
29. Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28: 1411-1424.
30. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother. 2001;35:997-1003.
31. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116.
32. Guenette L, Moisan J, Preville M, Boyer R. Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records. J Clin Epidemiol. 2005;58:924-933.
33. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-567.
34. Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med. 2009;32:278-284.
35. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902-907.
36. Sastre J, Olaguibel J, Vega JM, Del Pozo V, Picado C, Lopez Viña A. Cut-offpoints for defining asthma control in three versions of the Asthma Control Questionnaire. J Asthma. 2010;47:865-870.
37. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006;100:616-621.
38. Ulrik CS, Backer V, Soes-Petersen U, Lange P, Harving H, Plaschke PP. The patient's perspective: adherence or nonadherence to asthma controller therapy? J Asthma. 2006;43:701-704.
39. Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13:172-175.
40. Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res. 2005;58:403-415.
41. Menckeberg TT, Bouvy ML, Bracke M, Hugtenburg JG, Lammers JW, Raaijmakers JA. Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids. Br J Clin Pharmacol. 2008;66: 255-260.
42. Janson SL, Earnest G, Wong KP, Blanc PD. Predictors of asthma medication nonadherence. Heart Lung. 2008;37:211-218.
43. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40: 1280-1288.
44. Heijmans MJWM, Rijken PM. Kerngegevens Zorg-2003, Monitor Zorg-en Leefsituatie van mensen met astma en mensen met COPD. [Monitor care and living situation of people with asthma and people with COPD]. NIVEL. Dutch.
45. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1810-1817.
46. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. Thorax. 2003;58:851-854.
47. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21:1196-1203.
48. Narhi U, Airaksinen M, Tanskanen P, Enlund H. The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients. Patient Educ Couns. 2001;43:171-177.